Evidence map›Paper›PMID 42457654›Full record

ArticleTranslational psychiatry2026

Early deviations from normative brain morphology and cortical microstructure in schizophrenia spectrum disorders.

Claudio Alemán-Morillo, Natalia García-San-Martín, Richard Ai Bethlehem, Patricia Segura, Chloé Gomez, Alessia Pasquini, Pablo Salguero-Quirós, Lena Dorfschmidt, Manuel Muñoz-Caracuel, Rosa Ayesa-Arriola and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Claudio Alemán-MorilloDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain.ORCID http://orcid.org/0009-0008-3691-9672
Natalia García-San-MartínDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain.ORCID http://orcid.org/0000-0002-2071-2289
Richard Ai BethlehemDepartment of Psychology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-0714-0685
Patricia SeguraDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain.
Chloé GomezDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain.ORCID http://orcid.org/0009-0007-0082-1959
Alessia PasquiniDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain.ORCID http://orcid.org/0009-0006-7895-5140
Pablo Salguero-QuirósDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain.ORCID http://orcid.org/0009-0009-6333-6023
Lena DorfschmidtDepartment of Child and Adolescent Psychiatry and Behavioral Science, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-0447-1104
Manuel Muñoz-CaracuelMental Health Service, Virgen del Rocío University Hospital; Seville, Spain. Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/University of Seville / CIBERSAM, ISCIII, Seville, Spain.
Rosa Ayesa-ArriolaDepartment of Psychiatry. Marqués de Valdecilla University Hospital, IDIVAL, CIBERSAM, ISCIII, School of Medicine, University of Cantabria, Santander, Spain.
Javier Vázquez-BourgonDepartment of Psychiatry. Marqués de Valdecilla University Hospital, IDIVAL, CIBERSAM, ISCIII, School of Medicine, University of Cantabria, Santander, Spain.ORCID http://orcid.org/0000-0002-5478-3376
John SucklingDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-5098-1527
Miguel Ruiz VeguillaMental Health Service, Virgen del Rocío University Hospital; Seville, Spain. Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/University of Seville / CIBERSAM, ISCIII, Seville, Spain.
Benedicto Crespo-FacorroMental Health Service, Virgen del Rocío University Hospital; Seville, Spain. Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/University of Seville / CIBERSAM, ISCIII, Seville, Spain.
Rafael Romero-GarcíaDepartment of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, Seville, Spain. rr480@cam.ac.uk.ORCID http://orcid.org/0000-0002-5199-4573

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In schizophrenia spectrum disorders (SSD), structural alterations of the gray matter (GM) and white matter (WM) have been widely described. However, the complex interplay between early disease-related changes and ongoing brain maturation challenges our ability to identify early biomarkers. In this study, we investigated structural abnormalities and their association with symptoms in a drug-naïve or minimally medicated sample comprising 113 patients with SSD and 112 neurotypical controls. Specifically, we derived centile scores using normative modelling from cortical thickness (CT), and subcortical volumes derived from structural MRI images, and diffusion tensor imaging-derived (DTI) WM tract fractional anisotropy (FA). In addition, we derived raw cortical mean diffusivity (cMD) metrics from DTI. Compared to controls, SSD participants showed reduced CT centiles, ventricular enlargement, and subcortical centile reductions in the hippocampus, thalamus, amygdala, and nucleus accumbens. SSD was also associated with widespread increases in cMD. We also explored associations among these structural markers, identifying significant relationships between CT centiles and raw cMD, as well as between subcortical centiles and FA tract-based centiles. No interaction with SSD diagnosis was found. Furthermore, positive symptoms correlated negatively with CT and FA tract-based centiles, and showed widespread positive associations with raw cMD, whereas negative symptoms showed no associations. These findings underscore multimodal brain abnormalities that originate early in the course of SSD and their distinct associations with symptoms. Our results support the potential of both normative modelling and diffusion imaging markers to identify individualized early brain changes in SSD Among these, cMD emerges as a potential marker of SSD-related microstructural alterations.

Indexed as

BrainCerebral CortexSchizophreniaWhite MatterAdultAnisotropyCase-Control StudiesDiffusion Tensor ImagingFemaleGray MatterHumansMagnetic Resonance ImagingMaleYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.